These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9617534)

  • 21. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
    Skouby SO; Wagner HH; Andersen O
    Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of abnormal circulating insulin levels to atherosclerosis.
    Stout RW
    Atherosclerosis; 1977 May; 27(1):1-13. PubMed ID: 857812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism.
    Coata G; Ventura F; Lombardini R; Ciuffetti G; Cosmi EV; Di Renzo GC
    Contraception; 1995 Sep; 52(3):151-7. PubMed ID: 7587186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.
    Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):334-43. PubMed ID: 2196805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
    Devenport MH; Crook D; Wynn V; Lees LJ
    Br J Clin Pharmacol; 1989 Jun; 27(6):851-9. PubMed ID: 2547410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K; Viegas OA; Loke DF; Ratnam SS
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk.
    Godsland IF; Crook D
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1528-36. PubMed ID: 8178902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
    Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
    Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contraception.
    Mishell DR
    Am J Dis Child; 1978 Sep; 132(9):912-20. PubMed ID: 356591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions with oral contraceptives.
    Fotherby K
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2153-9. PubMed ID: 2256524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and metabolic considerations of long-term oral contraceptive use.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1955-63. PubMed ID: 1605285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral contraceptives and metabolic changes].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.